Section Arrow
Quote
GENB.NASDAQ
- Generate Biomedicines, Inc.
Quotes are at least 15-min delayed:2026/03/09 12:12 EDT
Regular Hours
Last
 12.05
+0.85 (+7.59%)
Day High 
12.29 
Prev. Close
11.2 
1-M High
15.32 
Volume 
271.73K 
Bid
12
Ask
12.1
Day Low
11.624 
Open
12.09 
1-M Low
11 
Market Cap 
1.43B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High 15.32 
52-W Low 11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.96/--
Enterprise Value
1.43B
Balance Sheet
Book Value Per Share
-4.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.89M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ANTXAN2 Therapeutics5.89+3.05+107.39%-- 
IBRXImmunityBio8.27-0.38-4.39%-- 
IOVAIovance Biotherapeutics5.4202+0.2852+5.55%-- 
ACRSAclaris Therapeutics3.275+0.215+7.03%-- 
RLMDRelmada Therapeutics6.02+1.57+35.28%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology byusing machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.